↓ Skip to main content

NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma

Overview of attention for article published in Cancer Cell International, September 2019
Altmetric Badge

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
7 Mendeley